APA

Zastrozhin M. S., Brodyansky V. M., Skryabin V. Y., Grishina E. A., Ivashchenko D. V., Ryzhikova K. A., Savchenko L. M., Kibitov A. O., Bryun E. A. & Sychev D. A. (2017). Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder. : Pharmacogenomics and personalized medicine.

Chicago

Zastrozhin Mikhail Sergeevich, Brodyansky Vadim Markovich, Skryabin Valentin Yurievich, Grishina Elena Anatolievna, Ivashchenko Dmitry Vladimirovich, Ryzhikova Kristina Anatolievna, Savchenko Ludmila Mikhaylovna, Kibitov Alexander Olegovich, Bryun Evgeny Alekseevich and Sychev Dmitry Alekseevich. 2017. Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder. : Pharmacogenomics and personalized medicine.

Harvard

Zastrozhin M. S., Brodyansky V. M., Skryabin V. Y., Grishina E. A., Ivashchenko D. V., Ryzhikova K. A., Savchenko L. M., Kibitov A. O., Bryun E. A. and Sychev D. A. (2017). Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder. : Pharmacogenomics and personalized medicine.

MLA

Zastrozhin Mikhail Sergeevich, Brodyansky Vadim Markovich, Skryabin Valentin Yurievich, Grishina Elena Anatolievna, Ivashchenko Dmitry Vladimirovich, Ryzhikova Kristina Anatolievna, Savchenko Ludmila Mikhaylovna, Kibitov Alexander Olegovich, Bryun Evgeny Alekseevich and Sychev Dmitry Alekseevich. Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder. : Pharmacogenomics and personalized medicine. 2017.